[1]. Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis.
Respiratory investigation [巻]64 [号]2 [頁]101367 （2026年） [査読] 有
[DOI] [2]. Clinical Characteristics and Prevalence of Apical Scarring at Chest CT in a Healthy Population.
Radiology. Cardiothoracic imaging [巻]8 [号]1 [頁]e250190 （2026年） [査読] 有
[DOI] [3]. Amiodarone-Induced Pneumonia Without Foamy Macrophages in the BALF: A Diagnostic Challenge Unveiled by Cryobiopsy
Respirol Case Rep （2026年） [査読] 有
[4]. Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD
Scientific reports （2026年） [査読] 有
[5]. Psychological palliative care for patients with interstitial lung disease in Japan: A secondary analysis of a National Survey of Japanese Respiratory Physicians
Respiratory investigation （2026年） [査読] 有
[6]. Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study
SCIENTIFIC REPORTS [巻]15 [号]1 （2025年） [査読] 有
[DOI] [7]. Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.
Thorax （2025年） [査読] 有
[DOI] [8]. Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy.
Clinical lung cancer （2025年） [査読] 有
[9]. Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia.
Scientific reports [巻]15 [号]1 [頁]35623 （2025年） [査読] 有
[10]. Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials.
BMC cancer [巻]25 [号]1 [頁]1494 （2025年） [査読] 有
[11]. Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.
JTO clinical and research reports [巻]6 [号]8 [頁]100847 （2025年） [査読] 有
[DOI] [12]. PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.
International journal of molecular sciences [巻]26 [号]15 （2025年） [査読] 有
[13]. Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis.
Scientific reports [巻]15 [号]1 [頁]25537 （2025年） [査読] 有
[14]. Incidence and clinical significance of acute exacerbation of interstitial lung disease in patients with primary Sjögren's syndrome.
Respiratory investigation [巻]63 [号]5 [頁]838 -843 （2025年） [査読] 有
[DOI] [15]. Quantitative Assessment of Systemic Sclerosis-Related Interstitial Lung Disease via 3D-Imaging
Respirology （2025年） [査読] 有
[機関リポジトリ][16]. Depression and its association with mortality in idiopathic pulmonary fibrosis: A real-world data analysis.
Respiratory medicine [頁]108185 （2025年） [査読] 有
[DOI] [17]. Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis.
ERJ open research [巻]11 [号]3 （2025年） [査読] 有
[18]. Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells
NPJ Precis Oncol （2025年） [査読] 有
[19]. Differences in Radiological and Pathological Findings by ANCA-Subtype in ANCA-Positive Idiopathic Interstitial Pneumonias
Clin Respir J （2025年） [査読] 有
[20]. Obesity impairs ciliary function and mucociliary clearance in the murine airway epithelium.
American journal of physiology. Lung cellular and molecular physiology （2024年） [査読] 有
[DOI] [21]. Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease
ARTHRITIS & RHEUMATOLOGY （2024年） [査読] 有
[DOI] [機関リポジトリ][22]. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Emerging microbes & infections [巻]12 [号]1 [頁]2155250 （2023年） [査読] 有
[DOI] [23]. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
Cancer immunology, immunotherapy : CII （2023年） [査読] 有
[DOI] [24]. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists.
Respirology (Carlton, Vic.) （2023年） [査読] 有
[DOI] [機関リポジトリ][25]. A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
The European respiratory journal （2023年） [査読] 有
[DOI] [機関リポジトリ][26]. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation.
American journal of respiratory cell and molecular biology [巻]68 [号]2 [頁]201 -212 （2023年） [査読] 有
[DOI] [27]. Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer.
Global health & medicine [巻]4 [号]6 [頁]301 -308 （2022年） [査読] 有
[DOI] [28]. Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume.
The European respiratory journal [巻]60 [号]6 （2022年） [査読] 有
[DOI] [29]. Prognostic significance of radiological pleuroparenchymal fibroelastosis in complex lung disease: a multicentre retrospective cohort study.
Thorax （2022年） [査読] 有
[DOI] [30]. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
Respiratory investigation [巻]60 [号]6 [頁]779 -786 （2022年） [査読] 有
[DOI] [31]. End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation.
Respiratory research [巻]23 [号]1 [頁]294 （2022年） [査読] 有
[DOI] [32]. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
BMC pulmonary medicine [巻]22 [号]1 [頁]387 （2022年） [査読] 有
[DOI] [33]. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
International journal of molecular sciences [巻]23 [号]16 （2022年） [査読] 有
[DOI] [34]. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis.
BMC pulmonary medicine [巻]22 [号]1 [頁]290 （2022年） [査読] 有
[DOI] [35]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal of cancer research and clinical oncology （2022年） [査読] 有
[DOI] [36]. Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia.
Scientific reports [巻]12 [号]1 [頁]9303 （2022年） [査読] 有
[DOI] [37]. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis.
Respiratory research [巻]23 [号]1 [頁]142 （2022年） [査読] 有
[DOI] [38]. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium.
BMC pulmonary medicine [巻]22 [号]1 [頁]186 （2022年） [査読] 有
[DOI] [39]. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
Respiratory research [巻]23 [号]1 [頁]79 （2022年） [査読] 有
[DOI] [40]. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Thorax （2022年） [査読] 有
[DOI] [機関リポジトリ][41]. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Respiratory research [巻]23 [号]1 [頁]57 （2022年） [査読] 有
[DOI] [42]. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Thorax [巻]77 [号]2 [頁]143 -153 （2022年） [査読] 有
[DOI] [43]. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma.
Autophagy [頁]1 -13 （2022年） [査読] 有
[DOI] [44]. Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report.
Respiratory medicine case reports [巻]37 [頁]101632 （2022年） [査読] 有
[DOI] [45]. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the mutation.
Respiratory medicine case reports [巻]36 [頁]101608 （2022年） [査読] 有
[DOI] [46]. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Therapeutic advances in chronic disease [巻]13 [頁]20406223221108395 （2022年）
[DOI] [47]. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Cancer immunology, immunotherapy : CII [巻]71 [号]1 [頁]203 -217 （2022年） [査読] 有
[DOI] [48]. Transient leukocytopenia following combination therapy for COVID-19.
Respiratory investigation [巻]60 [号]1 [頁]158 -161 （2022年） [査読] 有
[DOI] [49]. EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report
JTO clinical and research reports [巻]3 [号]1 [頁]100264 （2022年） [査読] 有
[DOI] [50]. Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report.
JTO clinical and research reports [巻]3 [号]1 [頁]100263 （2022年） [査読] 有
[DOI] [51]. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
BMC pulmonary medicine [巻]21 [号]1 [頁]409 （2021年） [査読] 有
[DOI] [52]. Response.
Chest [巻]160 [号]6 [頁]e683 -e685 （2021年） [査読] 有
[DOI] [53]. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
Chest [巻]160 [号]6 [頁]2149 -2157 （2021年） [査読] 有
[DOI] [機関リポジトリ][54]. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Respiratory research [巻]22 [号]1 [頁]290 （2021年） [査読] 有
[DOI] [55]. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
Respiratory investigation [巻]59 [号]6 [頁]709 -740 （2021年） [査読] 有
[DOI] [56]. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Respiratory investigation [巻]59 [号]6 [頁]827 -836 （2021年） [査読] 有
[DOI] [機関リポジトリ][57]. MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
JTO clinical and research reports [巻]2 [号]11 [頁]100239 （2021年） [査読] 有
[DOI] [58]. Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
BMC pulmonary medicine [巻]21 [号]1 [頁]309 （2021年） [査読] 有
[DOI] [59]. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis.
Scientific reports [巻]11 [号]1 [頁]18579 （2021年） [査読] 有
[DOI] [60]. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
Scientific reports [巻]11 [号]1 [頁]15502 （2021年） [査読] 有
[DOI] [61]. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.
Scientific reports [巻]11 [号]1 [頁]14999 （2021年） [査読] 有
[DOI] [62]. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
BMC pulmonary medicine [巻]21 [号]1 [頁]221 （2021年） [査読] 有
[DOI] [63]. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
Allergology international : official journal of the Japanese Society of Allergology [巻]70 [号]3 [頁]351 -359 （2021年） [査読] 有
[DOI] [64]. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
Lung [巻]199 [号]3 [頁]289 -298 （2021年） [査読] 有
[DOI] [65]. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
Scientific reports [巻]11 [号]1 [頁]9120 （2021年） [査読] 有
[DOI] [66]. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
Respiratory research [巻]22 [号]1 [頁]115 （2021年） [査読] 有
[DOI] [67]. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease.
Respiratory medicine [巻]182 [頁]106420 （2021年） [査読] 有
[DOI] [68]. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray.
Scientific reports [巻]11 [号]1 [頁]7669 （2021年） [査読] 有
[DOI] [69]. Management of Myositis-Associated Interstitial Lung Disease.
Medicina (Kaunas, Lithuania) [巻]57 [号]4 （2021年） [査読] 有
[DOI] [70]. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Respirology (Carlton, Vic.) [巻]26 [号]4 [頁]370 -377 （2021年） [査読] 有
[DOI] [機関リポジトリ][71]. Exposure to PM is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study.
Respiratory research [巻]22 [号]1 [頁]80 （2021年） [査読] 有
[DOI] [72]. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.
Thorax [巻]76 [号]3 [頁]248 -255 （2021年） [査読] 有
[DOI] [73]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
BMC pulmonary medicine [巻]21 [号]1 [頁]63 （2021年） [査読] 有
[DOI] [74]. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
Nature communications [巻]12 [号]1 [頁]1032 （2021年） [査読] 有
[DOI] [75]. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Chest [巻]159 [号]6 [頁]2334 -2345 （2021年） [査読] 有
[DOI] [機関リポジトリ][76]. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Investigational new drugs [巻]39 [号]1 [頁]210 -216 （2021年） [査読] 有
[DOI] [機関リポジトリ][77]. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [巻]27 [号]2 [頁]373 -378 （2021年） [査読] 有
[DOI] [機関リポジトリ][78]. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Respirology (Carlton, Vic.) [巻]26 [号]2 [頁]171 -179 （2021年） [査読] 有
[DOI] [機関リポジトリ][79]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.
Scientific reports [巻]11 [号]1 [頁]1682 （2021年） [査読] 有
[DOI] [80]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Respiration; international review of thoracic diseases [巻]100 [号]1 [頁]19 -26 （2021年） [査読] 有
[DOI] [81]. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide.
Cancer treatment and research communications [巻]29 [頁]100493 （2021年） [査読] 有
[DOI] [82]. Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts.
American journal of translational research [巻]13 [号]11 [頁]12318 -12337 （2021年） [査読] 有
[83]. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View.
Journal of pain and symptom management [巻]60 [号]5 [頁]933 -940 （2020年） [査読] 有
[DOI] [機関リポジトリ][84]. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.
Respiratory research [巻]21 [号]1 [頁]282 （2020年） [査読] 有
[DOI] [85]. Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias.
Respiratory medicine [巻]174 [頁]106201 （2020年） [査読] 有
[DOI] [機関リポジトリ][86]. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Microbiology and immunology [巻]64 [号]10 [頁]666 -678 （2020年） [査読] 有
[DOI] [87]. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
Respiratory medicine [巻]171 [頁]106078 （2020年） [査読] 有
[DOI] [機関リポジトリ][88]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620953783 （2020年） [査読] 有
[DOI] [89]. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer.
JAMA network open [巻]3 [号]9 [頁]e2011818 （2020年） [査読] 有
[DOI] [90]. Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations.
The European respiratory journal [巻]56 [号]2 （2020年） [査読] 有
[DOI] [91]. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [巻]15 [号]8 [頁]1317 -1327 （2020年） [査読] 有
[DOI] [機関リポジトリ][92]. Imaging mass spectrometry to visualise increased acetylcholine in lungs of asthma model mice.
Analytical and bioanalytical chemistry [巻]412 [号]18 [頁]4327 -4341 （2020年） [査読] 有
[DOI] [93]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620935774 （2020年） [査読] 有
[DOI] [94]. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Respiratory investigation [巻]58 [号]3 [頁]177 -184 （2020年） [査読] 有
[DOI] [機関リポジトリ][95]. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) [巻]143 [頁]47 -54 （2020年） [査読] 有
[DOI] [96]. Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis.
The European respiratory journal [巻]55 [号]5 （2020年） [査読] 有
[DOI] [97]. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan.
Respiratory investigation [巻]58 [号]2 [頁]91 -101 （2020年） [査読] 有
[DOI] [98]. Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]10 [号]1 [頁]3324 （2020年） [査読] 有
[DOI] [99]. Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620906327 （2020年） [査読] 有
[DOI] [100]. CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes.
BMC pulmonary medicine [巻]20 [号]1 [頁]21 （2020年） [査読] 有
[DOI] [101]. Pneumothorax in connective tissue disease-associated interstitial lung disease.
PloS one [巻]15 [号]7 [頁]e0235624 （2020年） [査読] 有
[DOI] [102]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]9 [号]1 [頁]18750 （2019年） [査読] 有
[DOI] [103]. 市中肺炎に対するレボフロキサシン・スイッチ療法の有効性・安全性の検討
新薬と臨牀 (株)医薬情報研究所 [巻]68 [号]12 [頁]1519 -1531 （2019年） [査読] 有
[104]. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
Rheumatology (Oxford, England) [巻]58 [号]12 [頁]2143 -2152 （2019年） [査読] 有
[DOI] [105]. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3299 -3304 （2019年） [査読] 有
[DOI] [106]. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3267 -3271 （2019年） [査読] 有
[DOI] [107]. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Respiratory medicine [巻]159 [頁]105811 （2019年） [査読] 有
[DOI] [108]. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Respiratory investigation [巻]57 [号]6 [頁]552 -560 （2019年） [査読] 有
[DOI] [109]. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Respirology (Carlton, Vic.) （2019年） [査読] 有
[DOI] [110]. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
The Journal of infection [巻]79 [号]4 [頁]341 -348 （2019年） [査読] 有
[DOI] [111]. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]46 [号]8 [頁]935 -942 （2019年） [査読] 有
[DOI] [112]. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Respirology (Carlton, Vic.) [巻]24 [号]8 [頁]792 -798 （2019年） [査読] 有
[DOI] [113]. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Scientific reports [巻]9 [号]1 [頁]10484 （2019年） [査読] 有
[DOI] [114]. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Cancer chemotherapy and pharmacology [巻]84 [号]1 [頁]147 -153 （2019年） [査読] 有
[DOI] [115]. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Respiratory medicine [巻]154 [頁]102 -108 （2019年） [査読] 有
[DOI] [116]. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Investigational new drugs [巻]37 [号]3 [頁]531 -537 （2019年） [査読] 有
[DOI] [117]. Physiological and morphological differences of airways between COPD and asthma-COPD overlap.
Scientific reports [巻]9 [号]1 [頁]7818 （2019年） [査読] 有
[DOI] [118]. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.
The European respiratory journal [巻]53 [号]5 （2019年） [査読] 有
[DOI] [119]. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
The Journal of rheumatology [巻]46 [号]5 [頁]509 -517 （2019年） [査読] 有
[DOI] [120]. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine [巻]199 [号]8 [頁]1031 -1033 （2019年） [査読] 有
[DOI] [121]. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Chronic respiratory disease [巻]16 [頁]1479972318809476 （2019年） [査読] 有
[DOI] [122]. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1333 -1342 （2019年） [査読] 有
[DOI] [123]. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
Journal of asthma and allergy [巻]12 [頁]253 -261 （2019年） [査読] 有
[DOI] [124]. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1867 -1877 （2019年） [査読] 有
[DOI] [125]. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
Respiratory medicine [巻]146 [頁]76 -80 （2019年） [査読] 有
[DOI] [126]. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) [巻]45 [号]2 [頁]125 -131
[DOI]